KraneShares MSCI All China Health Care Index ETF
Not enough financial coverage to compute a composite score for KURE. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companykraneshares.com/kure
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
- IPO
- 2018
- HQ
- New York, NY, US
Price Chart
Valuation
- Market Cap
- $76.57M
- Div Yield
- 4.39%
Performance & Tape
- 52W High
- $21.88
- 52W Low
- $15.78
- 50D MA
- $17.20
- 200D MA
- $18.67
- Beta
- 0.50
- Avg Volume
- 21.33K
Get TickerSpark's AI analysis on KURE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our KURE Coverage
We haven't published any research on KURE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KURE Report →